Literature DB >> 11352289

Nasopharyngeal cancer and the Southeast Asian patient.

C Her1.   

Abstract

Because of a documented increased incidence, nasopharyngeal cancer should be considered when signs or symptoms of ear, nose and throat disease are present in patients from southern China (in particular, Hong Kong and the province of Guangdong) or Southeast Asia. Environmental factors, the Epstein-Barr virus and genetic factors have been associated with the development of nasopharyngeal cancer. Patients with this malignancy most often present with a cervical mass from metastatic spread to a lymph node. Other possible presentations include ipsilateral serous otitis, hearing loss, nasal obstruction, frank epistaxis, purulent or bloody rhinorrhea, and facial neuropathy or facial nerve palsies. Radiotherapy is often curative. The addition of chemotherapy has produced high response rates in local and regionally advanced disease.

Entities:  

Mesh:

Year:  2001        PMID: 11352289

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  13 in total

1.  Disparities in mortality patterns among Canadian immigrants and refugees, 1980-1998: results of a national cohort study.

Authors:  Marie DesMeules; Jenny Gold; Sarah McDermott; Zhenyuan Cao; Jennifer Payne; Bryan Lafrance; Bilkis Vissandjée; Erich Kliewer; Yang Mao
Journal:  J Immigr Health       Date:  2005-10

2.  Inhibitory effects of dietary glucosylceramides on squamous cell carcinoma of the head and neck in NOD/SCID mice.

Authors:  Kazunori Fujiwara; Kazuyuki Kitatani; Kei Fukushima; Hiroaki Yazama; Hisanori Umehara; Mitsunori Kikuchi; Yasuyuki Igarashi; Hiroya Kitano; Toshiro Okazaki
Journal:  Int J Clin Oncol       Date:  2010-11-06       Impact factor: 3.402

3.  Cancer incidence among Canadian immigrants, 1980-1998: results from a national cohort study.

Authors:  Sarah McDermott; Marie Desmeules; Roxanne Lewis; Jenny Gold; Jennifer Payne; Bryan Lafrance; Bilkis Vissandjée; Erich Kliewer; Yang Mao
Journal:  J Immigr Minor Health       Date:  2011-02

4.  Association of ABCC2 and CDDP-Resistance in Two Sublines Resistant to CDDP Derived from a Human Nasopharyngeal Carcinoma Cell Line.

Authors:  Si Ming Xie; Wei Yi Fang; Teng Fei Liu; Kai Tai Yao; Xue Yun Zhong
Journal:  J Oncol       Date:  2010-06-13       Impact factor: 4.375

5.  Dietary glucosylceramides suppress tumor growth in a mouse xenograft model of head and neck squamous cell carcinoma by the inhibition of angiogenesis through an increase in ceramide.

Authors:  Hiroaki Yazama; Kazuyuki Kitatani; Kazunori Fujiwara; Misaki Kato; Mayumi Hashimoto-Nishimura; Katsuyuki Kawamoto; Kensaku Hasegawa; Hiroya Kitano; Alicja Bielawska; Jacek Bielawski; Toshiro Okazaki
Journal:  Int J Clin Oncol       Date:  2014-08-01       Impact factor: 3.402

6.  Massive nasal bleeding and hemodynamic instability associated with clopidogrel.

Authors:  Flávio E Nácul; Emanuela de Moraes; Carmen Penido; Roberto B Paiva; João G C Méier-Neto
Journal:  Pharm World Sci       Date:  2004-02

7.  Racial differences in nasopharyngeal carcinoma in the United States.

Authors:  Yu Wang; Yawei Zhang; Shuangge Ma
Journal:  Cancer Epidemiol       Date:  2013-09-12       Impact factor: 2.984

8.  Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients.

Authors:  Shuna Li; Lihua Hang; Yongming Ma; Chaoyang Wu
Journal:  J Cell Mol Med       Date:  2016-08-04       Impact factor: 5.310

9.  Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin.

Authors:  Si Ming Xie; Wei Yi Fang; Zhen Liu; Shuang Xi Wang; Xin Li; Teng Fei Liu; Wei Bing Xie; Kai Tai Yao
Journal:  J Transl Med       Date:  2008-10-04       Impact factor: 5.531

10.  Enhanced inhibitory effect of curcumin via reactive oxygen species generation in human nasopharyngeal carcinoma cells following purple-light irradiation.

Authors:  Dujuan Wang; Jiang Hu; Lin Lv; Xiuwen Xia; Jianzhong Liu; Xiaoyuan Li
Journal:  Oncol Lett       Date:  2013-05-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.